Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival?

被引：0
|
作者：
Kadri Altundag
机构：
[1] MKA Breast Cancer Clinic,
来源：
Breast Cancer Research and Treatment | 2017年 / 162卷
关键词：
Overall Survival; Metastatic Breast Cancer; Increase Mortality Risk; Debatable Issue; Metastatic Relapse;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：395 / 396
页数：1
相关论文
共 50 条
  • [1] Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival?
    Altundag, Kadri
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 162 (02) : 395 - 396
  • [2] Response to "Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival?"
    den Brok, Wendie D.
    Speers, Caroline H.
    Gondara, Lovedeep
    Baxter, Emily
    Tyldesley, Scott K.
    Lohrisch, Caroline A.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 162 (02) : 397 - 398
  • [3] Response to “Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival?”
    Wendie D. den Brok
    Caroline H. Speers
    Lovedeep Gondara
    Emily Baxter
    Scott K. Tyldesley
    Caroline A. Lohrisch
    Breast Cancer Research and Treatment, 2017, 162 : 397 - 398
  • [4] Surgery of the primary tumor in de novo metastatic breast cancer: To do or not to do?
    Criscitiello, C.
    Giuliano, M.
    Curigliano, G.
    De Laurentiis, M.
    Arpino, G.
    Carlomagno, N.
    De Placido, S.
    Golshan, M.
    Santangelo, M.
    EJSO, 2015, 41 (10): : 1288 - 1292
  • [5] Breast surgery in de novo metastatic breast cancer
    Chan, P.
    Kuah, S.
    Lu, S.
    Goh, M. H.
    Chen, J.
    Tan, E. Y.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S79 - S79
  • [6] Survival in Young Women with De Novo or Recurrent Metastatic Breast Cancer
    Varella, Leticia
    Zheng, Yue
    Rosenberg, Shoshana
    Kirkner, Gregory
    Snow, Craig
    Ruddy, Kathryn
    Tamimi, Rulla
    Peppercorn, Jeffrey
    Schapira, Lidia
    Borges, Virginia
    Come, Steven
    Collins, Laura
    Warner, Ellen
    Dibble, Kate
    Winer, Eric
    Partridge, Ann
    CANCER RESEARCH, 2024, 84 (09)
  • [7] Surgery of the Primary Tumor in De Novo Metastatic Breast Cancer Confers No Survival Benefit
    Murali-Nanavati, Sridevi
    Nair, Nita S.
    Badwe, Rajendra
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 3) : 787 - 788
  • [8] Surgery of the Primary Tumor in De Novo Metastatic Breast Cancer Confers No Survival Benefit
    Sridevi Murali-Nanavati
    Nita S. Nair
    Rajendra Badwe
    Annals of Surgical Oncology, 2021, 28 : 787 - 788
  • [9] Overall survival with locoregional surgery in de novo metastatic breast cancer
    Ren Chongxi
    Sun Jianna
    Kong Lingjun
    CANCER RESEARCH, 2023, 83 (05)
  • [10] Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
    D J A Lobbezoo
    R J W van Kampen
    A C Voogd
    M W Dercksen
    F van den Berkmortel
    T J Smilde
    A J van de Wouw
    F P J Peters
    J M G H van Riel
    N A J B Peters
    M de Boer
    P G M Peer
    V C G Tjan-Heijnen
    British Journal of Cancer, 2015, 112 : 1445 - 1451
12345